Clinical Trial Update: A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BL-B01D1, SI-B003, and their combination in recurrent or metastatic cervical cancer and other gynecologic malignancies; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• BL-B01D1
• BL-B01D1 + SI-B003
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Cervical Cancer | Phase 2 | Status: RECRUITING